Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMRN | AMGN | GILD | VRTX | BIIB |
| Company | Biomarin Pharmaceuticals | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 92.69 | 270.63 | 66.58 | 404.50 | 198.97 |
| High | 93.01 | 274.86 | 67.18 | 406.83 | 205.75 |
| Low | 91.00 | 269.64 | 66.36 | 399.29 | 198.97 |
| Last | 91.20 | 273.01 | 67.08 | 400.76 | 201.99 |
| Change | -0.86 | -0.53 | +0.05 | -4.15 | +8.81 |
| % Change | -0.93% | -0.19% | +0.07% | -1.02% | +4.56% |
| Volume | 1,599,600 | 2,467,100 | 8,467,000 | 806,400 | 3,265,600 |
| 20-Day Average Volume | 1,405,800 | 2,172,705 | 6,490,535 | 970,000 | 1,263,995 |
| Previous Close | 92.06 | 273.54 | 67.03 | 404.91 | 193.18 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 89.25 | 271.55 | 69.07 | 403.29 | 202.16 |
| 20-Day Raw Stochastic | 72.09% | 44.22% | 14.81% | 32.03% | 44.61% |
| 20-Day Relative Strength | 57.05% | 48.18% | 33.12% | 44.82% | 42.70% |
| Weighted Alpha | -2.14 | +11.15 | -20.78 | +16.09 | -34.68 |
| Today's Opinion | 40% Buy | 40% Sell | 100% Sell | 8% Buy | 100% Sell |
| Previous Opinion | 32% Buy | 40% Sell | 100% Sell | 24% Buy | 100% Sell |
| Last Month's Opinion | 72% Sell | 24% Buy | 88% Sell | 40% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.81% since 04/17/24 | +3.39% since 04/17/24 | +0.22% since 04/17/24 | +1.95% since 04/17/24 | +5.12% since 04/17/24 |
| Low | 88.29 on 04/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 93.01 on 04/24/24 | 274.86 on 04/24/24 | 67.68 on 04/23/24 | 406.86 on 04/23/24 | 205.75 on 04/24/24 |
| 1-Month | |||||
| %Chg | +7.13% since 03/22/24 | -1.14% since 03/22/24 | -7.62% since 03/22/24 | -3.58% since 03/22/24 | -7.39% since 03/22/24 |
| Low | 84.70 on 03/25/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 93.36 on 04/15/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 | 218.26 on 03/25/24 |
| 3-Month | |||||
| %Chg | -1.20% since 01/24/24 | -10.64% since 01/24/24 | -15.65% since 01/24/24 | -6.27% since 01/24/24 | -18.28% since 01/24/24 |
| Low | 83.44 on 03/15/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 94.15 on 02/23/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 448.40 on 01/30/24 | 251.99 on 01/31/24 |
| 6-Month | |||||
| %Chg | +9.42% since 10/24/23 | -1.13% since 10/24/23 | -14.17% since 10/24/23 | +8.50% since 10/24/23 | -19.88% since 10/24/23 |
| Low | 76.02 on 11/02/23 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 341.90 on 11/16/23 | 189.44 on 04/19/24 |
| High | 99.56 on 12/14/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 17,374,852 | 146,720,288 | 83,457,512 | 104,652,640 | 28,080,836 |
| Shares Outstanding, K | 188,734 | 536,376 | 1,245,077 | 258,459 | 145,361 |
| Annual Sales | 2,419,230,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | 167,650,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 646,210,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 | 2,386,300,000 |
| Last Quarter Net Income | 20,380,000 | 767,000,000 | 1,429,000,000 | 968,800,000 | 249,700,000 |
| 60-Month Beta | 0.31 | 0.58 | 0.19 | 0.35 | -0.02 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.49 on 02/22/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 | 2.95 on 02/13/24 |
| Latest Earnings Date | 04/24/24 | 05/02/24 | 04/25/24 | 05/06/24 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 71.59 | 14.58 | 9.96 | 29.76 | 13.18 |